Saisubramanian Nagarajan

7PUBLICATIONS
2CO-AUTHORS
Industrial biotechnology diagnostics (incl. biosensors)Major global burdens of diseaseMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 01, 2022
New tools to mitigate drug resistance in Enterobacteriaceae - Escherichia coli and Klebsiella pneumoniae.

Niranjana Sri Sundaramoorthy, Prakash Shankaran, Vidhya Gopalan

|Feb 15, 2021
Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model.

Niranjana Sri Sundaramoorthy, Subramaniam Thothathri, Muthumeenakshi Bhaskaran

|Dec 29, 2019
Restoring colistin sensitivity in colistin-resistant E. coli: Combinatorial use of MarR inhibitor with efflux pump inhibitor.

Niranjana Sri Sundaramoorthy, Pavithira Suresh, Subramaniapillai Selva Ganesan

|Jun 29, 2019
Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells.

Rene Christena Lowrence, Selva Ganesan Subramaniapillai, Venkatasubramanian Ulaganathan

|Mar 30, 2019
Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli.

Subhashree Bharathan, Niranjana Sri Sundaramoorthy, Harini Chandrasekaran

Pageof 2